Is Radiotherapy Necessary for Stage 1 Testicular Seminoma?
![]() |
Lee, Jung-Ae
(Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Park, Won (Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lim, Do-Hoon (Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Ahn, Yong-Chan (Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Huh, Seung-Jae (Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Yu, Jeong-Il (Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Choi, Han-Yong (Departments of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Hyun-Moo (Departments of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Cho, Eun-Yoon (Departments of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97:63-70 DOI ScienceOn |
2 | Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66 DOI ScienceOn |
3 | Choo R, Thomas G, Woo T, et al. Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma. Int J Radiat Oncol Biol Phys 2005;61:736-740 DOI PUBMED ScienceOn |
4 | Fossa SD, Horwich A, Russell JM, et al. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 1999; 17:1146 PUBMED |
5 | Aparicio J, Germa JR, Garcia del Muro X, et al. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group Study. J Clin Oncol 2005;23:8717-8723 DOI ScienceOn |
6 | Daugaard G, Petersen PM, Rorth M. Surveillance in stage I testicular cancer. Apmis 2003;111:76-83 DOI ScienceOn |
7 | Jacobsen GK, Mellemgaard A, Engelholm SA, Moller H. Increased incidence of sarcoma in patients treated for testicular seminoma. Eur J Cancer 1993;29A:664-668 PUBMED |
8 | Jones WG, Fossa SD, Mead GM, et al. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 2005;23:1200-1208 DOI ScienceOn |
9 | Warde P, Specht L, Horwich A, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002;20:4448-4452 DOI ScienceOn |
10 | Oliver RT, Mason MD, Mead GM, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 2005;366:293-300 DOI PUBMED ScienceOn |
11 | Zagars GK, Ballo MT, Lee AK, Strom SS. Mortality after cure of testicular seminoma. J Clin Oncol 2004;22:640-647 DOI ScienceOn |
12 | van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, et al. Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol 1993;11:415-424 PUBMED |
![]() |